EP0201732A2 - Bêta-2-mimétiques du type des 4-amoniphényléthanolamines pour la prévention des ulcères stomacaux - Google Patents
Bêta-2-mimétiques du type des 4-amoniphényléthanolamines pour la prévention des ulcères stomacaux Download PDFInfo
- Publication number
- EP0201732A2 EP0201732A2 EP86104951A EP86104951A EP0201732A2 EP 0201732 A2 EP0201732 A2 EP 0201732A2 EP 86104951 A EP86104951 A EP 86104951A EP 86104951 A EP86104951 A EP 86104951A EP 0201732 A2 EP0201732 A2 EP 0201732A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- prevention
- peptic ulcers
- treatment
- tert
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CCC(C*1)CC(*)=C1NC Chemical compound CCC(C*1)CC(*)=C1NC 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Definitions
- the above compound according to the invention is administered orally and to the feed to the fattening animal, in particular calves, in a daily dose of 1 to 10 mcg / kg body weight, but preferably of 1.5 to 5 mcg / kg body weight.
- the compound 1- (4-amino-3,5, -dichforphenyl) -2-tertbutyfamina-ethanol hydrochloride was administered in a daily dose of 2 mcg / kg body weight, divided into 2 doses, which was added to the feed, 32 at the beginning The treatment continued to give calves approximately 70 days old and approximately 100 kg in weight compared to a control group of the same size.
- the substance administered is well tolerated. This has, for example, an LD 50 on the mouse of 176 mg / kg po. Furthermore, there were no side effects when applying this substance, for example, there were no significant differences between the two groups in the haematological examination and the enzymes SGOT, CPK, LDH and GLDH, which was carried out on a sample basis.
- the application according to the invention of a compound of the above general formula I thus increases the tolerance of the calf's stomach to the age and size of the animals inadequate or unphysiological feed composition in an unforeseeable manner. It thus avoids the previously unavoidable losses in the intensive fattening of white meat cats of all related cattle breeds (in particular the brown cattle, Fleckvieh, Charolais, black and white, red and angled breeds), which over a period of approx. 5 months up to a weight of approx 250 kg are fattened by mortality due to ulcers and poor daily weight gain due to peptic abomasal ulcers.
- composition of milk exchange feed is Composition of milk exchange feed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3514725 | 1985-04-24 | ||
| DE19853514725 DE3514725A1 (de) | 1985-04-24 | 1985-04-24 | Ss(pfeil abwaerts)2(pfeil abwaerts)-mimetica vom typ der 4-amino-phenylaethanolamine zur verhinderung von peptischen magen-geschwueren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0201732A2 true EP0201732A2 (fr) | 1986-11-20 |
| EP0201732A3 EP0201732A3 (fr) | 1989-08-02 |
Family
ID=6268944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP86104951A Withdrawn EP0201732A3 (fr) | 1985-04-24 | 1986-04-10 | Bêta-2-mimétiques du type des 4-amoniphényléthanolamines pour la prévention des ulcères stomacaux |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0201732A3 (fr) |
| JP (1) | JPS61251621A (fr) |
| AU (1) | AU585602B2 (fr) |
| DE (1) | DE3514725A1 (fr) |
| DK (1) | DK186386A (fr) |
| IL (1) | IL78579A (fr) |
| NZ (1) | NZ215926A (fr) |
| ZA (1) | ZA863025B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2838923A1 (de) * | 1978-09-07 | 1980-04-03 | Thomae Gmbh Dr K | Verwendung von phenylaethanolaminen als antiphlogistica |
| IL60530A (en) * | 1979-08-16 | 1984-10-31 | American Cyanamid Co | Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds |
| DE3104850A1 (de) * | 1981-02-11 | 1982-08-26 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neuer futterzusatz zur verbesserung des wachstums" |
| AU8612082A (en) * | 1982-07-16 | 1984-01-19 | Thomae, Karl G.M.B.H. | Phenylethanolamines and use thereof as animal growth promotors |
-
1985
- 1985-04-24 DE DE19853514725 patent/DE3514725A1/de not_active Withdrawn
-
1986
- 1986-04-10 EP EP86104951A patent/EP0201732A3/fr not_active Withdrawn
- 1986-04-22 IL IL78579A patent/IL78579A/xx unknown
- 1986-04-23 JP JP61094393A patent/JPS61251621A/ja active Pending
- 1986-04-23 ZA ZA863025A patent/ZA863025B/xx unknown
- 1986-04-23 NZ NZ215926A patent/NZ215926A/xx unknown
- 1986-04-23 DK DK186386A patent/DK186386A/da not_active Application Discontinuation
- 1986-04-24 AU AU56586/86A patent/AU585602B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ZA863025B (en) | 1987-12-30 |
| DK186386D0 (da) | 1986-04-23 |
| AU5658686A (en) | 1986-11-06 |
| JPS61251621A (ja) | 1986-11-08 |
| AU585602B2 (en) | 1989-06-22 |
| IL78579A (en) | 1989-03-31 |
| DK186386A (da) | 1986-10-25 |
| IL78579A0 (en) | 1986-08-31 |
| EP0201732A3 (fr) | 1989-08-02 |
| NZ215926A (en) | 1988-10-28 |
| DE3514725A1 (de) | 1986-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1620114C3 (de) | Schiffsche Basen von 2 Formyl chinoxalin 1,4 dioxiden | |
| DE2432799C2 (de) | 7-substituierte 5-Methyl-isoflavone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Metabolica | |
| DE2125245B2 (de) | Isoflavone und Verfahren zu deren Herstellung | |
| EP0589488A1 (fr) | (-)-Cimaterol et son usage comme médicament ou comme promoteur de croissance | |
| DE2423972A1 (de) | 2-phenyl-as-triazin-3,5(2h,4h)dione und deren herstellung | |
| DE2504193A1 (de) | Mittel zur verbesserung der harnstoffausnutzung in der tierfuetterung | |
| DE2945497A1 (de) | Derivate der d-2-hydroxy-4-methylmercaptobuttersaeure, verfahren zu deren herstellung und deren verwendung | |
| DE2129960C2 (de) | Thioureidoderivate enthaltende therapeutische Zusammensetzungen, Verfahren zu deren Herstellung sowie die Thioureidoderivate | |
| EP0057900B1 (fr) | Additif du fourrage favorisant la croissance | |
| EP0201732A2 (fr) | Bêta-2-mimétiques du type des 4-amoniphényléthanolamines pour la prévention des ulcères stomacaux | |
| EP0119446A2 (fr) | Dérivés d'aminophényléthylamine stimulant la croissance | |
| DE2921824A1 (de) | Diphenylaether, verfahren zu ihrer herstellung, und ihre verwendung zur behandlung von leberegelinfektionen | |
| DE2105112A1 (de) | Chinoxahn di Noxide und ihre Verwendung in einem pharmazeutischen Gemisch | |
| DE2212932A1 (de) | Verfahren zur Herstellung von Chinoxalin-di-N-oxiden | |
| DE2435248A1 (de) | 1,3-diamino-2-propanole, ein verfahren zu deren herstellung und ein dieselben enthaltendes mittel | |
| DE2755063A1 (de) | Verfahren zur foerderung des wachstums und verbesserung der futterausnutzung bei tieren | |
| DE1812471C3 (de) | Bis-Harnstoffaddukte von Macrolidantibiotica und diese enthaltende veterinärmedizinische Mittel sowie Futtermittel | |
| DE2526750B2 (de) | Calciumsalz von N-Monohydroxymethyl-L-lysin und Na, und NE -Bishydroxymethyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung zur Supplementierung von Futter für Wiederkäuer | |
| EP0260391A1 (fr) | Agent d'augmentation de rendement de porcs et volailles | |
| DE1695184A1 (de) | Verfahren zur Herstellung eines 5-Nitro-imidazols | |
| DE2056955A1 (de) | Verwendung von p Amino p ureidodiphenyl sulfon zur Behandlung der Marekschen Krank heit | |
| EP0130281A1 (fr) | Utilisation de sels de méthionine dans l'alimentation de ruminants | |
| DE2056758A1 (de) | Substituierte Metamlsauren | |
| AT209333B (de) | Verfahren zur Herstellung von neuen 5-Nitro-furfuryliden-hydrazinen | |
| DE1136705B (de) | Verfahren zur Herstellung von 2-(4'-Acetylpiperazino)-5-nitrothiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): BE CH DE FR GB IT LI LU NL SE |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): BE CH DE FR GB IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19891129 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19901103 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SALAMON, ERNST, DR. Inventor name: BRIGANTI, ALBERTO, DR. |